154 related articles for article (PubMed ID: 20422456)
1. Clinical significance of stanniocalcin 2 as a prognostic marker in gastric cancer.
Yokobori T; Mimori K; Ishii H; Iwatsuki M; Tanaka F; Kamohara Y; Ieta K; Kita Y; Doki Y; Kuwano H; Mori M
Ann Surg Oncol; 2010 Oct; 17(10):2601-7. PubMed ID: 20422456
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of endothelial cell specific molecule-1 (ESM-1) in gastric cancer.
Liu N; Zhang LH; Du H; Hu Y; Zhang GG; Wang XH; Li JY; Ji JF
Ann Surg Oncol; 2010 Oct; 17(10):2628-39. PubMed ID: 20383661
[TBL] [Abstract][Full Text] [Related]
3. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer.
Saito T; Kurashige J; Nambara S; Komatsu H; Hirata H; Ueda M; Sakimura S; Uchi R; Takano Y; Shinden Y; Iguchi T; Eguchi H; Ehata S; Murakami K; Sugimachi K; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864
[TBL] [Abstract][Full Text] [Related]
4. KAP1 is associated with peritoneal carcinomatosis in gastric cancer.
Yokoe T; Toiyama Y; Okugawa Y; Tanaka K; Ohi M; Inoue Y; Mohri Y; Miki C; Kusunoki M
Ann Surg Oncol; 2010 Mar; 17(3):821-8. PubMed ID: 19898899
[TBL] [Abstract][Full Text] [Related]
5. Down-regulated SPARCL1 is associated with clinical significance in human gastric cancer.
Li P; Qian J; Yu G; Chen Y; Liu K; Li J; Wang J
J Surg Oncol; 2012 Jan; 105(1):31-7. PubMed ID: 22161898
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of osteopontin expression in human gastric carcinoma.
Higashiyama M; Ito T; Tanaka E; Shimada Y
Ann Surg Oncol; 2007 Dec; 14(12):3419-27. PubMed ID: 17896150
[TBL] [Abstract][Full Text] [Related]
7. Expression of ERas oncogene in gastric carcinoma.
Kaizaki R; Yashiro M; Shinto O; Yasuda K; Matsuzaki T; Sawada T; Hirakawa K
Anticancer Res; 2009 Jun; 29(6):2189-93. PubMed ID: 19528480
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of Kallikrein-ralated peptidase 11 as a novel prognostic marker of gastric cancer based on immunohistochemistry.
Wen YG; Wang Q; Zhou CZ; Yan DW; Qiu GQ; Yang C; Tang HM; Peng ZH
J Surg Oncol; 2011 Oct; 104(5):516-24. PubMed ID: 21618246
[TBL] [Abstract][Full Text] [Related]
9. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
[TBL] [Abstract][Full Text] [Related]
10. STC2: a predictive marker for lymph node metastasis in esophageal squamous-cell carcinoma.
Kita Y; Mimori K; Iwatsuki M; Yokobori T; Ieta K; Tanaka F; Ishii H; Okumura H; Natsugoe S; Mori M
Ann Surg Oncol; 2011 Jan; 18(1):261-72. PubMed ID: 20734150
[TBL] [Abstract][Full Text] [Related]
11. [mRNA expression of IGF-IIand HGF in relation to microvascular density, tumor progression and prognosis of gastric carcinoma].
Zhao ZS; Ru GQ; Ma J
Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):673-7. PubMed ID: 15777506
[TBL] [Abstract][Full Text] [Related]
12. A large-scale study of MT1-MMP as a marker for isolated tumor cells in peripheral blood and bone marrow in gastric cancer cases.
Mimori K; Fukagawa T; Kosaka Y; Ishikawa K; Iwatsuki M; Yokobori T; Hirasaki S; Takatsuno Y; Sakashita H; Ishii H; Sasako M; Mori M
Ann Surg Oncol; 2008 Oct; 15(10):2934-42. PubMed ID: 18661187
[TBL] [Abstract][Full Text] [Related]
13. The clinical significance of vimentin-expressing gastric cancer cells in bone marrow.
Iwatsuki M; Mimori K; Fukagawa T; Ishii H; Yokobori T; Sasako M; Baba H; Mori M
Ann Surg Oncol; 2010 Sep; 17(9):2526-33. PubMed ID: 20358301
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance.
Hashiguchi Y; Nishida N; Mimori K; Sudo T; Tanaka F; Shibata K; Ishii H; Mochizuki H; Hase K; Doki Y; Mori M
Int J Oncol; 2012 May; 40(5):1477-82. PubMed ID: 22322911
[TBL] [Abstract][Full Text] [Related]
15. The significance of PITX2 overexpression in human colorectal cancer.
Hirose H; Ishii H; Mimori K; Tanaka F; Takemasa I; Mizushima T; Ikeda M; Yamamoto H; Sekimoto M; Doki Y; Mori M
Ann Surg Oncol; 2011 Oct; 18(10):3005-12. PubMed ID: 21479692
[TBL] [Abstract][Full Text] [Related]
16. Detection of cancer cells disseminated in bone marrow using real-time quantitative RT-PCR of CEA, CK19, and CK20 mRNA in patients with gastric cancer.
Fujita Y; Terashima M; Hoshino Y; Ohtani S; Kashimura S; Kanzaki N; Osuka F; Kogure M; Gotoh M
Gastric Cancer; 2006; 9(4):308-14. PubMed ID: 17235634
[TBL] [Abstract][Full Text] [Related]
17. Metastasis-associated long non-coding RNA drives gastric cancer development and promotes peritoneal metastasis.
Okugawa Y; Toiyama Y; Hur K; Toden S; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Kusunoki M; Boland CR; Goel A
Carcinogenesis; 2014 Dec; 35(12):2731-9. PubMed ID: 25280565
[TBL] [Abstract][Full Text] [Related]
18. Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers.
Sakakura C; Hasegawa K; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Yazumi S; Yamagishi H; Okanoue T; Chiba T; Hagiwara A
Clin Cancer Res; 2005 Sep; 11(18):6479-88. PubMed ID: 16166423
[TBL] [Abstract][Full Text] [Related]
19. c-Met expression in gastric cancer with liver metastasis.
Amemiya H; Kono K; Itakura J; Tang RF; Takahashi A; An FQ; Kamei S; Iizuka H; Fujii H; Matsumoto Y
Oncology; 2002; 63(3):286-96. PubMed ID: 12381909
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of L1CAM is associated with tumor progression and prognosis via ERK signaling in gastric cancer.
Ito T; Yamada S; Tanaka C; Ito S; Murai T; Kobayashi D; Fujii T; Nakayama G; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Kodera Y
Ann Surg Oncol; 2014 Feb; 21(2):560-8. PubMed ID: 24046108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]